Shuttle Pharmaceuticals Holdings, Inc. SEC filings SHPH
Shuttle Pharmaceuticals Holdings, Inc. has 307 filings in SEC EDGAR's recent list, going back to Jan 31, 2019. Its latest annual report, Form ARS, was filed on Apr 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Sep 24, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 22, 2026 (auditor change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Sep 2, 2026 | — |
| DEFA14A | Additional proxy material | Aug 13, 2026 | — |
| DEF 14A | Proxy statement | Aug 13, 2026 | Aug 13, 2026 |
| PRE 14A | Preliminary proxy statement | Aug 3, 2026 | Aug 3, 2026 |
| DEFA14A | Additional proxy material | May 12, 2026 | — |
| DEF 14A | Proxy statement | Apr 20, 2026 | Apr 20, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 10, 2026 | Apr 10, 2026 |
| DEF 14A | Proxy statement | May 6, 2025 | May 6, 2025 |
| DEF 14A | Proxy statement | Mar 31, 2025 | Mar 31, 2025 |
| PRE 14A | Preliminary proxy statement | Mar 19, 2025 | Mar 19, 2025 |
| DEF 14A | Proxy statement | Jun 20, 2024 | Jun 20, 2024 |
| PRE 14A | Preliminary proxy statement | Jun 10, 2024 | Jun 10, 2024 |
| DEF 14A | Proxy statement | Oct 20, 2023 | Oct 20, 2023 |
| DEF 14C | Information statement | Jun 16, 2023 | Jun 16, 2023 |
| PRE 14C | Filing | Jun 5, 2023 | Jun 5, 2023 |
| DEF 14C | Information statement | Feb 13, 2023 | Feb 13, 2023 |
| PRE 14C | Filing | Feb 2, 2023 | Feb 2, 2023 |
| DEF 14A | Proxy statement | Nov 21, 2022 | Nov 21, 2022 |
Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SHPH (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Gaithersburg, MD
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1757499
- Former names
- Shuttle Pharmaceuticals Holdings, Inc. (until Oct 22, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.